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Summary
Brucella are facultative intracellular bacteria that
cause chronic infections by limiting innate immune
recognition. It is currently unknown whether
Brucella FliC flagellin, the monomeric subunit of
flagellar filament, is sensed by the host during
infection. Here, we used two mutants of Brucella
melitensis, either lacking or overexpressing flagel-
lin, to show that FliC hinders bacterial replication
in vivo. The use of cells and mice genetically defi-
cient for different components of inflammasomes
suggested that FliC was a target of the cytosolic
innate immune receptor NLRC4 in vivo but not in
macrophages in vitro where the response to FliC
was nevertheless dependent on the cytosolic
adaptor ASC, therefore suggesting a new pathway
of cytosolic flagellin sensing. However, our work
also suggested that the lack of TLR5 activity of
Brucella flagellin and the regulation of its synthe-
sis and/or delivery into host cells are both part
of the stealthy strategy of Brucella towards
the innate immune system. Nevertheless, as a
flagellin-deficient mutant of B. melitensis was
found to cause histologically demonstrable inju-
ries in the spleen of infected mice, we suggested
that recognition of FliC plays a role in the immu-
nological stand-off between Brucella and its host,
which is characterized by a persistent infection
with limited inflammatory pathology.
Introduction
The mammalian innate immune system relies on a limited
number of pattern recognition receptors (PRRs) to detect
microbial-derived molecules during infection and subse-
quently trigger an appropriate immune response to the
invading pathogen. These microbial features are often
referred to as PAMPs for pathogen-associated molecular
patterns. The PRRs include Toll-like receptors (TLRs),
which sense PAMPs on the cell surface or in endosomes
(Kawai and Akira, 2011), and nucleotide-binding domain
and leucine-rich repeat containing (NLRs) proteins, which
are cytosolic receptors responding to PAMPs and endog-
enous danger signals (Brodsky and Medzhitov, 2009;
Lamkanfi and Dixit, 2009). After stimulus recognition,
TLRs initiate multiple signalling pathways involved in the
innate inflammatory and antimicrobial responses, as well
as in the initiation and control of adaptive immune
responses (Kawai and Akira, 2011). In contrast, upon
stimulation, several NLRs, including NLRP1 (also known
as NALP1), NLRP3 (NALP3 or cryopyrin) and NLRC4
(Ipaf) assemble inflammasomes, which are multiprotein
complexes responsible for activation of the inflammatory
cysteine protease caspase-1 (Schroder and Tschopp,
2010).
Bacterial flagellin, the monomeric subunit of flagellar
filament, is a PAMP for both systems. Extracellular flag-
ellin is detected by TLR5 (Hayashi et al., 2001) that acti-
vates the MyD88-dependent signalling pathway, leading
to the nuclear translocation of NF-kB, and the activation of
mitogen-activated protein kinases (MAPK), ultimately
inducing the secretion of proinflammatory cytokines and
chemokines, such as IL-8 (Eaves-Pyles et al., 2001;
Gewirtz et al., 2001; Yu et al., 2003). On the other hand,
flagellin injected into the cytoplasm of macrophages
through bacterial virulence-associated secretion systems
is sensed by NLRC4 in association with NAIP5, another
member of the NLR family (Kofoed and Vance, 2011;
Zhao et al., 2011). Activation of caspase-1 within the
Received 20 September, 2012; revised 1 November, 2012; accepted
23 November, 2012. *For correspondence. Jean-Jacques Letesson:
E-mail jean-jacques.letesson@fundp.ac.be; Tel. (+32) 81 72 44 02;
Fax (+32) 81 72 44 20. Renée M. Tsolis: E-mail rmtsolis@
ucdavis.edu; Tel. (+1) 530 754 8497; Fax (+1) 530 752 7240.
†Both authors contributed equally to this work.
Cellular Microbiology (2013) 15(6), 942–960 doi:10.1111/cmi.12088
First published online 7 January 2013
© 2012 John Wiley & Sons Ltd
cellular microbiology
NLRC4 inflammasome leads to the maturation and
release of biologically active proinflammatory cytokines
IL-1b and IL-18 (van de Veerdonk et al., 2011). Moreover,
this inflammasome can trigger a proinflammatory form of
cell death known as pyroptosis (Bergsbaken et al., 2009).
Finally, it has been shown that NLRC4 plays a role in
maintaining a normal endosome–lysosome trafficking of
phagocytized bacteria within macrophages (Amer et al.,
2006; Akhter et al., 2009). There is evidence that both
TLR5 and NLRC4 play a role in controlling in vivo infec-
tions caused by pathogenic bacteria including Salmonella
enterica serotype Typhimurium (Feuillet et al., 2006; Broz
et al., 2010), Legionella pneumophila (Hawn et al., 2003;
Amer et al., 2006) and Pseudomonas aeruginosa (Feuillet
et al., 2006; Sutterwala et al., 2007; Franchi et al., 2012).
However, bacterial countermeasures to avoid flagellin
recognition by the innate immune system have also been
described. Helicobacter pylori and Campylobacter jejuni
escape TLR5 recognition as a result of changes in the
amino acid sequence of flagellin (Andersen-Nissen et al.,
2005), and it has been suggested that S. Typhimurium
downregulates fliC expression during macrophage infec-
tion to avoid a deleterious strong activation of NLRC4
inflammasome (Cummings et al., 2006; Miao et al.,
2010a).
Brucella spp. are Gram-negative bacteria that cause
brucellosis, a zoonosis of worldwide importance. In the
natural reservoir hosts, including wild and domestic
animals, these intracellular pathogens cause abortion and
infertility. Humans are accidental hosts and Brucella
melitensis and Brucella abortus are the most frequent
cause of human infection (Corbel, 1997). A key charac-
teristic of Brucella infection is its chronic nature. Indeed,
animals can remain infected for years, and Brucella
causes a protracted debilitating disease in untreated
humans that can result in serious clinical complications
(Young, 1995). As a result, brucellosis has an important
economic impact on livestock and remains a major public
health concern in endemic countries (Pappas et al.,
2006).
An important aspect of Brucella virulence is its capacity
to survive, replicate and persist within infected cells (Atluri
et al., 2011). Persistence of Brucella within cells relies at
least in part on its ability to control the intracellular traf-
ficking of its vacuole in order to avoid lysosomal degra-
dation and to gain access to its replicative niche derived
from the endoplasmic reticulum (Anderson and Cheville,
1986). Moreover, the success of Brucella lies in its
stealthy strategy to cope with the innate immune system.
First, the structural features of the Brucella envelope allow
it to avoid sustained recognition by PRRs and subsequent
strong inflammatory responses at the onset of infection
(Barquero-Calvo et al., 2007). For example, Brucella pro-
duces a lipopolysaccharide that signals poorly through
TLR4, compared to other bacteria (Lapaque et al., 2006;
Barquero-Calvo et al., 2007). In addition, Brucella can
actively control the inflammatory response by producing a
protein that interferes with TLR-dependent signalling
pathways (Salcedo et al., 2008; Radhakrishnan et al.,
2009; Sengupta et al., 2009). Along with the lack of cyto-
toxicity of Brucella for highly parasitized host cells, all the
above-mentioned features could render it less noticeable
by the host innate immune system than other pathogens
(Gross et al., 2000; Barquero-Calvo et al., 2007; Salcedo
et al., 2008). Nonetheless, Brucella spp. have virulence
factors such as a VirB type IV secretion system (T4SS)
(O’Callaghan et al., 1999), cyclic b-1,2-glucan (Briones
et al., 2001; Arellano-Reynoso et al., 2005) and flagellar
genes (Fretin et al., 2005) that are required for Brucella to
persist within its host. Although our previous studies
focused on the flagellum and its role in persistent infec-
tion, it is unknown whether Brucella flagellin, FliC, is
sensed by the host during infection. Here, we combined
host and pathogen genetic approaches to assess the
potential of Brucella flagellin to stimulate innate immune
responses.
Results
Mice fail to control infection by flagellin-deficient
B. melitensis mutants
In a previous study, insertional inactivation of genes
located in the three flagellar loci of B. melitensis was
reported to result in a marked attenuation of its virulence
in mice (Fretin et al., 2005). At that time, it was assumed
that, as described in enterobacteriaceae, the fliC gene
was not expressed in mutants of genes encoding basal
flagellar structures. However, we recently demonstrated
that the flagellar expression hierarchy of Brucella is not
conventional, as the flagellin subunit is still produced in
mutants deficient in the hook or basal body (Ferooz et al.,
2011). To evaluate the specific impact of the absence of
FliC flagellin on the virulence of B. melitensis, non-polar
mutants of fliC (DfliC) and flbT (DflbT) (Ferooz et al., 2011)
were used to infect murine macrophages and BALB/c
mice. The FlbT regulator of B. melitensis is specifically
required for the production of FliC, most likely by allowing
translation of the fliC mRNA (Ferooz et al., 2011). Accord-
ingly, flagellin was detected neither in the DfliC nor in the
DflbT strain harvested at the early exponential phase of
growth, whereas the protein is produced by the isogenic
wild type (wt) strain (Fig. 1A).
We first compared the intracellular growth of B. meliten-
sis DfliC and DflbT to that of wt bacteria in RAW264.7
murine macrophages. No difference in colony-forming
units (CFUs) was detected over a 48 h time-course
(Fig. 1B). Similar results were obtained in HeLa cells (data
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not shown). Consistent with a normal multiplication in
endoplasmic reticulum-derived vacuoles, both DfliC
mutant and its isogenic parental strain were found to
replicate within calnexin-positive compartments of HeLa
cells at 24 h post infection (p.i.) (data not shown).
Despite the absence of an obvious role for Brucella
flagellar genes in cellular models of infection, several
reports have shown that they are required for the estab-
lishment of a persistent infection in vivo (Fretin et al.,
2005; Zygmunt et al., 2006). To re-evaluate the role of
flagellar proteins in vivo, BALB/c mice were infected via
the intraperitoneal route with B. melitensis 16M DfliC,
DflbT and DfliF non-polar mutants. None of the mutants
was significantly attenuated 5 days p.i., as compared with
Fig. 1. Flagellin-deficient B. melitensis mutants infect macrophages in vitro with the same kinetics as wt bacteria but show enhanced
persistence in mice.
A. Western blot analysis of the production of flagellin (FliC, upper panel) by B. melitensis strains harvested at the early log phase and the log
phase of growth in 2YT rich medium. Anti-Omp89 detection was used as a loading control (lower panel). Data are representative of two
independent experiments. DfliC pfliC is the complemented strain.
B. Intracellular replication of B. melitensis 16M wt and DfliC strains in RAW264.7 murine macrophages. Error bars represent the standard
deviation of triplicates in one representative experiment out of three.
C–D. Infection kinetics in the spleens of wt BALB/c mice (n = 5) inoculated i.p. with 4 ¥ 104 CFUs of B. melitensis 16M wt, DfliC,
complemented DfliC pfliC, DflbT or DfliF strains.
E. Infection kinetics in the spleens of wt C57BL/6 mice (n = 5) inoculated i.p. with 4 ¥ 104 CFUs of B. melitensis 16M wt or DfliC strains. Data
represent the mean CFUs per organ and error bars represent standard deviation. Results have been analysed by ANOVA I after testing the
homogeneity of variance (Bartlett). ** and *** denote highly significant (P < 0.01 and P < 0.001 respectively) differences in relation to wt
infection. These results are representative of at least two independent experiments.
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the parental strain (Fig. 1C and D). Moreover, we could
confirm that the basal body protein FliF is required for full
virulence. Indeed, the DfliF mutant was attenuated at 3
and 4 weeks p.i. (Fig. 1D). In contrast, the virulence of the
DfliC strain was exacerbated when compared to its iso-
genic parental strain, as DfliC-infected mice presented a
higher bacterial load in the spleen from 12 days until 60
days p.i. (Fig. 1C). A higher bacterial count was also
observed at the same times in the livers of mice infected
with the DfliC mutant (data not shown). Similarly, an
enhanced persistence of the DfliC strain in the spleens
of the resistant C57BL/6 mice has also been observed
(Fig. 1E). The use of a low-copy plasmid carrying fliC
gene along with its predicted flanking regulatory
sequences, which restores regulated production of flagel-
lin in the DfliC strain (Fig. 1A), allowed partial complemen-
tation of the phenotype of the newly constructed DfliC
mutant at 28 days p.i. and full complementation at 60 days
p.i. (Fig. 1C). Moreover, we could show that the DflbT
mutant had similar infection kinetics than the DfliC strain in
the spleen of BALB/c mice (Fig. 1D). This further supports
the fact that the apparent inability of the host to control
bacterial infection is specifically due to the lack of flagellin
production by Brucella.
Mice infected with B. melitensis DfliC mutant exhibit
severe splenic pathology
Brucella is known to induce splenomegaly in infected
hosts. During the course of a B. melitensis 16M infection
in BALB/c mice, the spleen weight increases and peaks
around 0.4 g (fourfold the spleen weight of an uninfected
mice) at 12 days p.i. Afterwards, the spleen weight
decreases but remains twice the normal value until the
end of the experiment (Fig. 2A). In contrast, we found that
the splenomegaly of mice infected with flagellin-deficient
mutants, while displaying kinetics similar to those of the wt
infection during the first 12 days, continued to increase
until 28 days p.i. and reached a plateau of almost five or
six times the normal spleen weight by the end of the
experiment (Fig. 2A for DfliC, data not shown for DflbT). A
similar exacerbation of splenomegaly was also observed
in C57BL/6 mice at 21 days p.i. with the DfliC mutant (data
not shown). This was in accordance with the enhanced
persistence of the flagellin-deficient mutants in mice
(Fig. 1C–E).
We further examined the splenic histopathology of
BALB/c mice infected for 28 days with wt or DfliC
B. melitensis strain. At this time, mice infected with the
Fig. 2. Enhanced persistence of B. melitensis DfliC in mice is associated with increased pathology.
A. Kinetics of splenomegaly in wt female BALB/c mice (n = 5) injected i.p. with 4 ¥ 104 CFUs of wt or DfliC strains of B. melitensis 16M. Data
represent the mean spleen weight and error bars represent standard deviation. Results have been analysed by ANOVA I after testing the
homogeneity of variance (Bartlett). *** denotes highly significant (P < 0.001) differences in relation to wt infection.
B. Splenic pathology caused by a 28-day infection was determined using the histopathology scoring system as described in Experimental
procedures. Data were analysed using a Mann–Whitney test, and the mean histopathology scores were significantly different (P = 0.009).
C. Representative photomicrographs (¥10) of histopathology of spleens from BALB/c mice uninfected or infected for 28 days with B. melitensis
wt or DfliC strain. WP, white pulp; T, thrombosis; black arrows, granuloma; white arrowhead, neutrophil infiltration. These results are
representative of at least two independent experiments.
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DfliC strain showed a markedly exacerbated splenic
inflammation characterized by increased vasodilation,
thrombosis, neutrophil infiltration and granuloma forma-
tion (Fig. 2B and C). In contrast, mice infected for 28 days
with wt B. melitensis had nearly normal splenic morphol-
ogy, as compared with non-infected mice.
Ectopic production of flagellin attenuates the virulence
of B. melitensis in vivo
Mice apparently fail to control infection caused by
B. melitensis 16M DfliC or DflbT at late time points. This
observation suggests that production of flagellin by Bru-
cella somehow influences the course of infection. To
further test this hypothesis, we engineered a B. melitensis
16M strain, designated BruFliCON, that constitutively
expresses a plasmid-encoded copy of fliC from Escheri-
chia coli Plac. Western blot analysis confirmed that, while
production of flagellin by wt bacteria is only detectable at
the early exponential phase of growth, BruFliCON pro-
duced higher levels of flagellin throughout in vitro growth
(Fig. 3A). Ectopic production of flagellin did not impair the
invasion and replication abilities of Brucella in macro-
phages in vitro (Fig. 3B). However, we found that the
BruFliCON strain was attenuated in vivo compared with wt
B. melitensis 16M. While no difference in splenic bacterial
load was observed between the two strains at 5 days p.i.
of BALB/c mice, 0.5 to 1 log fewer CFU of BruFliCON
bacteria were recovered at 12, 21 and 28 days p.i.
(Fig. 3C). Reduced colonization of BruFliCON was also
observed in the liver of infected BALB/c, and similar
results were also obtained with C57BL/6 mice (data not
shown).
Brucella flagellin lacks TLR5 agonist activity
The altered virulence of the DfliC and BruFliCON mutants
led us to hypothesize that Brucella flagellin is detected by
the host in order to mount a protective immune response.
To ascertain whether innate immune sensing of flagellin
contributes to enhanced control of systemic Brucella
infection, we first determined whether Brucella flagellin
possesses agonist activity for TLR5. To this end, epitope-
tagged FliC flagellins from Brucella (BruFliC-FLAG)
or S. enterica serotype Typhimurium (S. Typhimurium;
StFliC-FLAG) were expressed in an S. Typhimurium
fliCfljB mutant (EHW26) lacking endogenous flagellin
expression. Immunoblotting with the anti-FLAG antibody
demonstrated that both BruFliC-FLAG and StFliC-FLAG
were secreted to the supernatant in similar amounts
(Fig. 4A). Addition of the C-terminal FLAG tag to StFliC
prevents its assembly into flagellar filaments, thereby
allowing for a direct comparison of effects of flagellin
monomers in the absence of a confounding effect on
motility, as strains expressing either StFliC-FLAG or
BruFliC-FLAG were aflagellate and non-motile (data not
shown).
Culture supernatants of S. Typhimurium fliCfljB
expressing recombinant flagellins were used to treat two
Fig. 3. Constitutive production of flagellin does not impair
replication of B. melitensis 16M in macrophages in vitro, but
attenuates its virulence in vivo.
A. Western blot analysis of flagellin (FliC, upper panel) production
in wt and BruFliCON strains during early exponential and stationary
phases of growth in 2YT rich medium. Detection of Omp89 was
used as a loading control.
B. Intracellular replication of wt and BruFliCON strains in RAW264.7
murine macrophages. Error bars represent the standard deviation
of triplicates in one representative experiment out of two.
C. Infection kinetics in the spleens of wt BALB/c mice (n = 5)
inoculated i.p. with 4 ¥ 104 CFUs of wt or BruFliCON strain. Data
represent the mean CFUs per organ and error bars represent
standard deviation. Results have been analysed by ANOVA I after
testing the homogeneity of variance (Bartlett). ** denotes highly
significant (P < 0.01) difference in relation to wt infection. These
results are representative of at least two independent experiments.
946 M. Terwagne et al.
© 2012 John Wiley & Sons Ltd, Cellular Microbiology, 15, 942–960
Fig. 4. Brucella flagellin lacks TLR5 agonist activity.
A–C. FLAG-tagged flagellins from S. enterica serotype Typhimurium (StFliC) or B. abortus (BruFliC) were expressed in an S. Typhimurium
fliCfljB mutant, and culture supernatants containing recombinant flagellins were used to treat cells. (A) Western blot showing production
of bacterium-associated flagellins from S. Typhimurium wt (lane 1), S. Typhimurium fliCfljB mutant (lane 2), fliCfljB mutant expressing
StFliC-FLAG (lane 3) or fliCfljB mutant expressing BruFliC-FLAG (lane 4). Flagellins were detected both in the pellets (left panel) and
in the concentrated supernatants (right panel) of S. Typhimurium strains. Thirty nanograms of concentrated supernatant proteins from
S. Typhimurium strains expressing recombinant flagellins were used to treat HEK293/hTLR5 cells for 4 or 24 h (B) and T84 cells for 8 h (C).
IL-8 in cell supernatants was measured by ELISA.
D. Activation of p38 and ERK MAPK in T84 cells by purified recombinant flagellins from Brucella (GST-BruFliC) and S. Typhimurium
(GST-StFliC) was measured by Western blot analysis with anti-p38, anti-phosphorylated (P-)p38, anti-ERK and anti-P-ERK. Detection of
tubulin was used as a loading control. Purified flagellins treated with proteinase K (PK) were used as a control. All data shown are from an
individual experiment that was repeated at least twice with similar results.
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TLR5-expressing cell lines: HEK293/hTLR5 and the
colonic epithelial cell line T84 (Fig. 4B and C). Both cell
lines secreted interleukin 8 (IL-8) on infection with strains
expressing native or FLAG-tagged StFliC, demonstrating
that addition of the epitope tag to the C-terminus of flag-
ellin did not affect its TLR5 agonist activity. Stimulation of
IL-8 secretion was dependent on flagellin in both cell
lines, as culture supernatants from the fliCfljB mutant
elicited little (Fig. 4C) or no (Fig. 4B) IL-8. In contrast to
StFliC-FLAG, expression of BruFliC-FLAG did not elicit
IL-8 secretion above the level of the fliCfljB mutant.
Similar results were obtained when T84 or HEK293/
hTLR5 cells were infected with S. Typhimurium strains
expressing recombinant flagellins (data not shown). The
response to BruFliC did not appear to be delayed, as
extending the time of the assay to 24 h did not allow
detection of a response comparable to that elicited by
StFliC-FLAG (Fig. 4B). As a second readout for TLR5
signalling, we assayed activation of MAPK p38 and ERK
by treatment with purified, GST-tagged flagellins. Phos-
phorylation of both p38 and ERK was induced to a greater
extent by GST-StFliC than by GST-BruFliC, and notably
no increase in phosphorylation of ERK could be detected
after treatment with GST-BruFliC (Fig. 4D). Taken
together, these results demonstrate that compared to
S. Typhimurium flagellin, the ability of Brucella flagellin to
stimulate TLR5 signalling is greatly reduced.
Cytosolic sensing pathways detect Brucella flagellin
during infection of macrophages
In addition to TLR5, flagellin that enters the cytosol of host
macrophages can be sensed by the NLRC4/NAIP5
pathway (Kofoed and Vance, 2011; Zhao et al., 2011). To
determine whether cytosolic pathways could detect flag-
ellin during Brucella infection, we first used the TEM-1
b-lactamase assay to detect translocation of flagellin into
the cytosol of B. abortus-infected J774 macrophage-like
cells. For these experiments, J774 cells were infected
with B. abortus 2308 expressing either a C-terminally
tagged copy of Brucella flagellin or an irrelevant protein
(GST), from a multi-copy plasmid (pFlagTEM-1; Sun
et al., 2007). While cells infected with B. abortus express-
ing GST::Flag-TEM-1 showed no cytosolic b-lactamase
activity (no b-lactamase-positive cells in four experi-
ments), 0.94% (range: 0.3–2.1%) of cells infected with
B. abortus expressing the flagellin fusion protein were
b-lactamase-positive, suggesting potential access of low
amounts of flagellin to the cytosol of Brucella-infected
cells. Next, we determined whether, in primary macro-
phages, cytosolic flagellin could stimulate innate immune
responses. To this end, we compared the ability of
B. melitensis and its isogenic DfliC mutant to elicit IL-1b
secretion from primary bone marrow-derived macro-
phages (BMDM). Compared to B. melitensis wt, the DfliC
mutant elicited significantly reduced IL-1b secretion
(Fig. 5A). This reduction was not the result of differing
numbers of intracellular bacteria of the DfliC mutant, as
both the DfliC mutant and wt B. melitensis were present in
the same numbers (data not shown). This partial reduc-
tion in IL-1b secretion suggests that recognition of flagellin
contributes to activation of the caspase-1 inflammasome.
The mechanism of cytosolic flagellin sensing in the
context of intracellular infection was further investigated
using the B. melitensis FliCON strain, which expresses
flagellin constitutively. This strain, as well as a control
carrying the empty plasmid pBBR1MCS, was used to
infect immortalized BMDM from mice deficient in NLRC4
Fig. 5. B. abortus flagellin induces IL-1b in an NLRC4-independent manner.
A. Primary bone marrow-derived macrophages from C57BL/6 mice were primed with LPS and inoculated with B. melitensis 16M wt or the
DfliC mutant and IL-1b was measured in the culture supernatants by ELISA. Results are shown as the mean  standard deviation of data
from an individual experiment that was repeated four times with similar results.
B. Immortalized, LPS-primed C57BL/6 or Nlrc4-/- bone marrow-derived macrophages were inoculated with B. melitensis 16M wt or the
BruFliCON strain. IL-1b in the supernatant was measured at 6 h after inoculation. Data shown are combined from three independent
experiments with triplicate samples, and represent the mean  standard deviation of all data.
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(Fig. 5B). Constitutive expression of FliC did not affect the
ability of B. melitensis to survive intracellularly (Fig. 3B
and data not shown). As in LPS-primed BMDM the
amount of IL-1b was maximal at 6 h after infection with
Brucella (Fig. 5A), we looked at the IL-1b response only at
this time point. The BruFliCON strain elicited significantly
more IL-1b secretion than the control strain (Fig. 5B),
confirming data shown in Fig. 5A. While these results
suggested that under conditions of flagellin expression,
flagellin can be sensed by cytosolic PRRs that lead to
activation of caspase-1 and secretion of IL-1b, NLRC4
was not required for flagellin-dependent stimulation of
IL-1b secretion by BMDM in vitro (Fig. 5B).
Brucella flagellin elicits IL-1b secretion by a mechanism
that is distinct from the NLRC4/NAIP5 pathway
As B. melitensis is known to inhibit innate immune signal-
ling (Salcedo et al., 2008; Radhakrishnan et al., 2009;
Sengupta et al., 2009), we determined whether purified
flagellin, in the absence of other Brucella factors, would
signal similarly to flagellin expressed during cellular infec-
tion. For this purpose, purified GST-BruFliC and GST-
StFliC were introduced into the cytosol of BMDM using
the cationic lipid DOTAP (Franchi et al., 2006). Both
BruFliC and StFliC elicited dose-dependent secretion of
IL-1b from BMDM from C57BL/6 mice when introduced
into the cytosol using DOTAP (Fig. 6A). Neither GST,
DOTAP alone, nor recombinant flagellins in the absence
of DOTAP elicited any secretion of IL-1b (Fig. 6A and data
not shown). Comparison of IL-1b secreted in response to
equal amounts of StFliC or BruFliC suggested that the
proinflammatory activity of StFliC was slightly higher than
that of BruFliC (Fig. 6A). Secretion of IL-1b in response
to S. Typhimurium FliC was dependent on NLRC4 and
only partially dependent on the adaptor protein ASC
(apoptosis-associated speck-like protein), as reported
previously (Broz et al., 2010). In contrast, BruFliC elicited
IL-1b secretion that required ASC, but was independent of
NLRC4, at least in cultured BMDM (Fig. 6B and C). These
results suggested that in BMDM, Brucella flagellin was
sensed by a cytosolic mechanism that differs from the
NLRC4/NAIP5-dependent response to S. Typhimurium
FliC (Kofoed and Vance, 2011; Zhao et al., 2011).
The cytosolic flagellin-detection pathway is implicated in
the control of B. melitensis infection in vivo
To evaluate the potential impact of caspase-1 inflamma-
somes on the control of Brucella infection in vivo, we
infected Nlrc4-/- and Casp1-/- C57BL/6 mice with
B. melitensis 16M. Splenic bacterial count was examined
21 days p.i., a time at which wt mice manage to effectively
control infection caused by flagellin-producing Brucella
Fig. 6. Introduction of recombinant Brucella flagellin into the host
cell cytosol results in ASC-dependent, but NLRC4-independent
secretion of IL-1b. Graded amounts of GST-BruFliC and
GST-StFliC fusion proteins were delivered to the cytosol of
LPS-primed primary bone marrow-derived macrophages from
C57BL/6 (A), Nlrc4-/- (B) or Asc-/- (C) mice, using the cationic lipid
DOTAP. Treated macrophages were incubated for 3 h before
measurement of IL-1b in the supernatants by ELISA. Results are
expressed as the mean of triplicate samples, with error bars
representing the range of the data from one of two independent
experiments with the same outcome.
Brucella flagellin as innate immune signal 949
© 2012 John Wiley & Sons Ltd, Cellular Microbiology, 15, 942–960
strains (Figs 1C–E and 3C). At this time, we observed that
NLRC4 (Fig. 7A) and caspase-1 (Fig. 7B) deficiency mod-
erately but significantly affected the resistance of mice to
infection. This suggests that the NLRC4–caspase-1 axis
is required for the host to control B. melitensis 16M infec-
tion, possibly through recognition of cytosolic flagellin. To
further test this hypothesis, the BruFliCON strain was used
to infect Nlrc4-/- and Casp1-/- mice. As shown previously,
virulence of this strain is attenuated compared to wt
B. melitensis 16M, as the spleen of BruFliCON-infected
C57BL/6 mice contained less CFUs than those infected
by the wt strain (Fig. 7). Interestingly, this virulence defect
was rescued in mice deficient for the cytosolic flagellin
sensor NLRC4 (Fig. 7A) or the downstream caspase-1
(Fig. 7B). These data indicate that, in contrast to what has
been observed in vitro (Figs 5B and 6B), Brucella flagellin
can activate the NLRC4 inflammasome in vivo. Never-
theless, we found that the BruFliCON strain was still
attenuated (a significant 0.5 log decreased CFUs in the
spleen) compared to B. melitensis 16M wt in Nlrc4-/-
and Casp1-/- mice 21 days p.i. (Fig. 7). This suggests that
both inflammasome-dependent and inflammasome-
independent control of infection operates downstream
detection of Brucella flagellin in vivo. This hypothesis is
further supported by the finding that although Nlrc4-/- and
Casp1-/- mice infected with wt B. melitensis 16M had sig-
nificantly higher splenic bacterial counts than those of wt
mice, it remained significantly lower than those of mice
infected with the DfliC mutant (Fig. 7).
B. melitensis DfliC mutant fails to elicit early granuloma
formation in the spleen of infected mice
Chronic granulomatous inflammation in the spleen of
natural hosts, humans and mice is the hallmark of Bru-
cella infection (Spink et al., 1949; Enright et al., 1990).
Recently, we revealed the pivotal role of early splenic
granuloma formation in the ability of mice to control bac-
terial dissemination (Copin et al., 2012). Here, we used a
rabbit polyclonal serum raised against B. melitensis (anti-
Bru) with the aim to compare the distribution of putative
infected cells in the spleen of BALB/c mice inoculated with
B. melitensis 16M wt or DfliC strain. Five days after infec-
tion with B. melitensis 16M wt, clusters of cells stained
with anti-Bru (Bru-positive cells) were found equally in
white pulp and red pulp area of the spleen (Fig. 8). These
clusters consisted primarily of CD11b+ cells, suggesting
that they corresponded to the granuloma previously
described (Copin et al., 2012). Strikingly, at the same
time, the number of Bru-positive cell clusters counted in
splenic sections of DfliC-infected mice was reduced
(Fig. 8). This apparent defect in early splenic granuloma
formation suggests the importance of flagellin sensing by
the host for the orchestration of this typical tissue
response to Brucella infection.
Discussion
Intracellular survival and immune evasion both contribute
to persistence of Brucella in the host (Atluri et al., 2011).
Recent studies have shown that Brucella uses passive as
well as active mechanisms to evade detection by TLRs
of the innate immune system (Lapaque et al., 2006;
Barquero-Calvo et al., 2007; Salcedo et al., 2008; Rad-
hakrishnan et al., 2009; Sengupta et al., 2009). Accord-
ingly, the inflammatory response induced at the onset of
Brucella infection is lower than observed with pyogenic
infections such as salmonellosis (Barquero-Calvo et al.,
2007). Actually, brucellae are not entirely invisible to the
immune system, which can still detect them and shape a
Th1 response to control infection (Murphy et al., 2001;
Copin et al., 2007). However, the host immune response
Fig. 7. NLRC4 inflammasome is implicated in the control of B. melitensis infection in vivo. Wild type, Nlrc4-/- (A) and Casp1-/- (B) C57BL/6
mice (n = 5) were injected i.p. with 4 ¥ 104 CFUs of B. melitensis wt, BruFliCON or DfliC strain, as indicated in the figure. Mice were sacrificed
21 days post infection and CFUs per spleen were determined. These results are representative of at least two independent experiments. Data
have been analysed by ANOVA I after testing the homogeneity of variance (Bartlett). *, ** and *** denote significant (P < 0.05, P < 0.01 and
P < 0.001 respectively) differences in relation to C57BL/6 wt infection by wt bacteria. # and ## denote significant (P < 0.05 and P < 0.01
respectively) differences in relation to knock-out mice infection by wt bacteria.
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is not sufficient to eliminate bacteria, resulting in a chronic
state of infection characterized by a balance between
pathogen virulence and host resistance. The impact of
Brucella flagellin on infection had not been reported yet.
The data presented here suggest that flagellin plays a
crucial role in the interplay between Brucella and its host,
as its detection by the innate immune system is required
for the control of infection in vivo, although some charac-
teristics of Brucella flagellin would contribute to the
stealthy strategy of this pathogen.
The use of two mutants of B. melitensis 16M that
either overproduce or lack the FliC flagellin has shown
that this protein hinders bacterial replication in vivo.
Indeed, a strain engineered to ectopically produce flagel-
lin (BruFliCON) was attenuated in mice, whereas deletion
of fliC (DfliC) enhanced persistence of B. melitensis 16M
in these conditions. Our in vivo data are consistent with
studies reporting exacerbated infections caused by a
flagellin-deficient mutant of Salmonella enterica serovar
Typhimurium (Vijay-Kumar et al., 2006), L. pneumophila
(Molofsky et al., 2006) or Pseudomonas syringae pv.
Tabaci (Li et al., 2005), as well as virulence attenua-
tion due to flagellin overproduction by S. Typhimurium
(Salazar-Gonzalez et al., 2007; Miao et al., 2010a) and
Listeria monocytogenes (Grundling et al., 2004). These
findings also suggest that Brucella flagellin is an important
immune target during infection, and our work provides first
insight into the mechanisms involved.
TLR5 and the NLRC4/NAIP5 complex are the only pro-
teins currently known as innate immune sensors of extra-
cellular and cytoplasmic bacterial flagellin respectively
(Miao et al., 2007).
In agreement with a recent paper quoting that purified
Brucella flagellin does not induce expression of interferon-
inducible resistance proteins (IRGs) in murine macro-
phages (Lapaque et al., 2009), the data reported in this
paper allow us to conclude that Brucella flagellin is not a
TLR5 agonist. This is consistent with its atypical sequence
as it lacks the amino acid residues required to stimulate
this PRR (Andersen-Nissen et al., 2005). Thus, we
propose that Brucella evades TLR5-mediated detection,
and that it could be part of its stealthy strategy to avoid
activation of the innate immune system during the onset
of infection.
Cytosolic flagellin activates a complex comprising the
NLR family proteins NLRC4 and NAIP5 (Franchi et al.,
2006; Miao et al., 2006; Kofoed and Vance, 2011; Zhao
et al., 2011). This complex senses a highly conserved
region of the C-terminal part of the flagellin critical for
flagellum filament assembly (Yonekura et al., 2003), but
Fig. 8. The distribution of Bru-positive cells is different in the spleen of mice infected by the DfliC mutant, compared to wt infection.
Localization of Bru+ cells (green) and CD11b+ cells (red) in the spleen of BALB/c mice non-infected or infected with B. melitensis wt or the
DfliC strain. The graph represents the relative number of clusters of Bru+ cells. Errors bars are the standard deviation calculated on countings
of four mice from two independent experiments.
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that is required neither for flagellin translocation into the
host cell cytosol nor for TLR5 activation (Lightfield et al.,
2008). The C-terminal 35 amino acid residues are con-
served in Brucella FliC flagellin, as they share respec-
tively 46% and 40% identity with L. pneumophila FlaA and
S. Typhimurium FliC, both known to activate NLRC4
(Franchi et al., 2006; Zamboni et al., 2006) and sharing
themselves 60% identity. Recently, it has been proposed
that the minimal motif of flagellin sensed by NLRC4 com-
prises the highly conserved last C-terminal residues
VLSLL found in L. pneumophila FlaA and S. Typhimurium
FliC (Lightfield et al., 2008; Miao et al., 2010b). This motif
is semi-conserved in Brucella flagellin that bears an
ILSFR motif.
Our results suggest that, similar to what is seen with
L. pneumophila infection (Amer et al., 2006; Case et al.,
2009), the NLRC4–caspase-1 axis is involved in the
control of B. melitensis 16M in vivo (Fig. 7). However, the
absence of NLRC4 or caspase-1 stimulation in mice
infected with the flagellin-deficient B. melitensis 16M
DfliC or DflbT mutants cannot by itself account for the
inability of the host to control infection. Indeed, the rela-
tive differences of virulence between B. melitensis 16M
wt and DfliC strains were only partially reduced in Nlrc4-/-
and Casp1-/- mice (Fig. 7), indicating involvement of both
NLRC4/caspase-1-dependent and independent mecha-
nisms in the control of Brucella downstream flagellin
recognition. This contrasts with what is observed after
intratracheal infection of mice with L. pneumophila.
Indeed, in this case, the number of flaA mutants and wt
bacteria in the lungs of Nlrc4-/- and Casp1-/- is similar
(Amer et al., 2006; Case et al., 2009). Therefore, it sug-
gests that Brucella flagellin is an immune target not only
for the cytosolic sensor NLRC4 in vivo. The slight attenu-
ation of the BruFliCON strain compared to B. melitensis
16M wt in Nlrc4-/- and Casp1-/- mice 21 days p.i. (Fig. 7)
is consistent with the hypothesis that Brucella flagellin
stimulates another immune pathway in addition to the
NLRC4/caspase-1 axis. The ASC-dependent signalling
suggested by our ex vivo data (Fig. 6) could be this
additional pathway. Brucella FliC is the first flagellin
found to induce IL-1b secretion from macrophages
in vitro in an NLRC4-independent manner. Whether
other poor agonists of TLR5 such as flagellins from
e-Proteobacteria activate this uncommon pathway
remains to be determined.
Activation of innate immune pathways by flagellin
would play a role in limiting replication of Brucella in vivo.
Interestingly, we found that the lack of flagellin affected
the control of B. melitensis infection by both susceptible
BALB/c and resistant C57BL/6 mice (Fig. 1C–E). BALB/c
mice are known for their intrinsic reduced capacity to
mount a Th1 immune response and are subsequently
less able to control Brucella infections than C57BL/6
mice, having notably an increased bacterial load in the
spleens during the plateau phase (Fernandes et al.,
1996; Sathiyaseelan et al., 2006; Copin et al., 2007; Vitry
et al., 2012). The hypervirulence of the DfliC mutant in
BALB/c and C57BL/6 mice suggests that immune detec-
tion of flagellin in vivo activates one or several immune
effector mechanisms that are shared by both mouse
species and that are critical for the control of Brucella
infection. The immune effector mechanisms triggered by
flagellin detection during Brucella infection remain to be
uncovered. Processing of the proinflammatory cytokines
pro-IL-1b and pro-IL-18 (Raupach et al., 2006; Dinarello,
2009), pyroptosis (Bergsbaken et al., 2009; Miao et al.,
2010a) and control of phagosome maturation (Amer
et al., 2006; Akhter et al., 2009) that can all result from
caspase-1 activation are important processes for innate
immunity against bacterial pathogens (Brodsky and
Monack, 2009).
Besides its impact on the innate immune system, it is
known that bacterial flagellin is also a target of the adap-
tive immune response (Salazar-Gonzalez and McSorley,
2005). However, whether the adaptive immune system
responds to MHC class II-presented flagellin peptides
during infection by Brucella is currently not known.
While searching for immune effector mechanisms trig-
gered by flagellin detection and involved in the control of
Brucella replication in mice, we found that the DfliC mutant
fails to elicit early granulomatous response in the spleen
of mice infected for 5 days, a time at which the mutant is
found at a similar level as the wt strain (Fig. 8). Thus, we
suggest that detection of flagellin by the host would play a
role in early granuloma development during brucellosis.
Although the granulomatous response was stronger at 28
days p.i. (Fig. 2B), when the DfliC strain colonized spleens
at higher extent than wt, an early alteration in this
response could contribute to the apparent failure of mice
to control infections caused by the flagellin-deficient
mutants of B. melitensis 16M. Indeed, granulomatous
inflammation is the typical tissue response to Brucella
infection in both mice and humans (Spink et al., 1949;
Hunt and Bothwell, 1967; Enright et al., 1990), and
a recent study has demonstrated the crucial role of
early formation of splenic granuloma in the control of
B. melitensis 16M (Copin et al., 2012). Whether granu-
loma formation during infection by Brucella depends on
ASC, NLRC4 and/or caspase-1 is currently unknown. Up
to now, a role for the NLRC4 inflammasome in such a
response has never been reported. However, it was
recently shown that granuloma formation in chronic
Mycobacterium tuberculosis infection is dependent on
ASC, whereas it does not require caspase-1 (McElvania
Tekippe et al., 2010).
S. Typhimurium translocates flagellin from its
containing-vacuole into the cytosol of infected cells by a
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SPI1-T3SS-dependent but flagellar secretory apparatus-
independent process (Sun et al., 2007). Similarly, a Dot/
Icm T4SS-mediated flagellin translocation has been
suggested in the case of L. pneumophila (Molofsky et al.,
2006; Ren et al., 2006). Here, we show that Brucella
flagellin is also translocated into the host cell cytosol.
Interestingly, flagellin translocation was not seen when a
virB2 mutant was used to infect macrophages (data not
shown), suggesting that VirB T4SS may play a role in
flagellin translocation. Interestingly, a requirement for the
T4SS to elicit splenic microgranuloma formation has been
proposed (Rolan et al., 2009). According to our results, it
could be envisioned that the VirB T4SS of Brucella elicits
a granulomatous response by translocating flagellin.
However, as the T4SS is also essential for Brucella to
reach its replicative niche (Celli et al., 2003), additional
studies would be necessary to determine whether the role
of the T4SS in release of flagellin to the host cytosol is
direct or indirect. The TEM-1 b-lactamase reporter assay
has been previously used to demonstrate translocation of
S. Typhimurium flagellin into the cytosol of infected mac-
rophages (Sun et al., 2007). We observed that the amount
of flagellin translocated into cells by Brucella is far less
than by Salmonella. While flagellin could be detected in
the cytosol of 77.5% of macrophages infected for 4 h with
S. Typhimurium (Sun et al., 2007), less than 1% of cells
were positive 16 h after infection with B. abortus. There-
fore, although the intrinsic ability of Brucella and Salmo-
nella flagellin to induce IL-1b secretion from BMDM
appeared to be similar (Fig. 6), Brucella might evade acti-
vation of a robust innate immune response from cytosolic
PRRs by controlling the production and/or delivery of flag-
ellin into the host cell. Accordingly, we could show that the
attenuation of the BruFliCON strain that ectopically pro-
duces flagellin is due at least in part to a strong NLRC4
inflammasome activation in vivo (Fig. 7). Thus, we
propose that the tight regulation of flagellin synthesis
and/or delivery during infection is part of its stealthy strat-
egy. This has also been suggested for S. Typhimurium,
which downregulates the expression of fliC during mac-
rophage infection (Cummings et al., 2006).
In conclusion, we propose that flagellin is an important
molecular actor of the interplay between Brucella and its
host. Although flagellin escapes detection by TLR5 and
Brucella controls its production and/or delivery to the
infected host cell cytosol, its detection by cytosolic PRRs
initiates a response that results in an immunological
stand-off between Brucella and its host, leading to a per-
sistent infection with limited inflammatory pathology. The
increased bacterial tissue loads and destructive pathol-
ogy, seen with the flagellin-deficient mutant, demonstrate
that innate and possibly also adaptive recognition of flag-
ellin is a process that is important to the chronic and
stealthy nature of Brucella infection. As such, flagellin
could be considered as a ‘host protective factor’ (Shames
and Finlay, 2010) in the context of brucellosis.
Experimental procedures
Bacteria and growth conditions
Bacterial strains and plasmids are listed in Table 1. Cultures of
Brucella strains were freshly inoculated from frozen stock onto
2YT medium (10% yeast extract, 10 g l-1 tryptone, 5 g l-1 NaCl)
plates before subculturing aerobically at 37°C in 2YT broth sup-
plemented with appropriate antibiotics. LB broth was used for
Escherichia coli and Salmonella enterica serotype Typhimurium
(S. Typhimurium) cultures. Antibiotics were used at the follow-
ing concentrations: carbenicillin, 100 mg l-1; chloramphenicol,
30 mg l-1; kanamycin, 60 mg l-1; or nalidixic acid, 50 mg l-1.
Molecular techniques
DNA manipulations were performed according to standard tech-
niques (Ausubel et al., 1991). Primers used are listed in Table 2.
Generation of the complementation vector pRH001-fliC. fliC
coding sequence (cds) and its predicted upstream and down-
stream regulatory sequences were amplified by PCR using the
PfliC and tfliC primers pair. The PCR product (PfliC-fliC-tfliC) was
then cloned into the EcorRV site of pGEM. In a second step, this
fragment was excised using BamHI and XbaI, and inserted into
the corresponding sites of pMR10cat (R. Roberts, unpublished)
in the opposite orientation to the Plac.
Generation of the B. melitensis 16M FliCON strain. The fliC over-
expression vector pBBR1-fliC was obtained as follows: first, the
constitutive promoter of the lac operon Plac was amplified by
PCR using the Plac and fliC-Plac primers pair. In the resulting
PCR product, Plac is flanked by translation stop codons in all
three reading frame in 5′ and by the 21st fliC coding sequence
(cds) base pairs in 3′. fliC cds was amplified by PCR using the
BmfliC-F and BmfliC-R primers. A third PCR using the Plac and
BmfliC-R primers was used to ligate the two PCR products by
cohesive ends. Stop codons and close fusion of fliC cds to Plac
without any linker ensure the production of FliC flagellin that
does not bear additional N-terminal amino acid residues. The
PCR product (XbaI-Plac-fliC-BamHI) was then cloned into the
EcorRV site of pGEM. In a last step, this fragment was excised
using XbaI and BamHI, and inserted into the corresponding
sites of pBBR1 MCS-I (Kovach et al., 1994) in the opposite
orientation to the endogenous Plac. This gave rise to pBBR1-
Plac-fliC. This final construction was transformed into E. coli
strain S17-1 (Simon et al., 1983), and introduced into B. meliten-
sis 16M by conjugation.
Generation of C-terminally FLAG-tagged flagellins. A derivative
of the broad host range plasmid pBBR1MCS (pBBR1-FLAG) was
first generated by ligating a fragment containing ‘SphI-promoter-
NdeI-SalI-3x-Flag-STOP-PstI-SacI’ into pBBR1MCS4 treated
with SphI and SacI. The S. Typhimurium fliC gene was amplified
using primers StFliC-F and StFliC-R, and the resulting amplicon
was ligated into NdeI and SalI-digested pBBR1-FLAG to yield
plasmid pYHS1116, encoding StFliC-FLAG. The B. abortus fliC
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gene was amplified using primers BaFliC-F and BaFliC-R and
cloned in the same way to generate pYHS1073, encoding
BruFliC-FLAG. In both constructs, expression of the recombinant
proteins was controlled by a previously described constitutive
Brucella promoter, BMEII0193 (Eskra et al., 2001). The con-
structs were confirmed by DNA sequencing across the junction
fragments. Plasmids pYHS1116 (StFliC-FLAG) and pYHS1073
(BruFliC-FLAG) were introduced into a Salmonella fliC fljB
mutant (EHW26, Raffatellu et al., 2005) by electroporation. The
B. abortus and B. melitensis FliC proteins are identical except for
a substitution of Ala156 to Thr in B. abortus.
Generation of fusions to TEM-1 b-lactamase. To express BruFliC
fused with TEM-1, B. abortus fliC was amplified by using the
primer pair BaFliC-F and BaFliC-R. The amplicon was cloned into
pCR2.1, then subsequently digested with NdeI and PstI, and
ligated pFlagTEM-1 (Raffatellu et al., 2005) digested with the
same enzymes to yield pBaFliC-TEM-1. The expression of
BruFliC::TEM-1 in pBaFliC-TEM-1 is under the control of induc-
ible Trc promoter. Constructs expressing StFliC::TEM-1 were
described previously (Sun et al., 2007).
Generation of GST–flagellin fusion proteins. For construction of
plasmids expressing GST fused at the N-terminus of flagellins,
flagellin genes were amplified to delete predicted N-terminal
secretion domains. The fliC gene from S. Typhimurium was
amplified without its first 332 nucleotides using primer pair of
StFliC-F2 and StFliC-STOP-R. Similarly, B. abortus fliC lacking
its first 87 nucleotides was amplified using primer pair of
BaFliC-F2 and BaFliC-R2. Both amplicons were cloned in
pCR2.1, excised as BamHI/SalI fragments and ligated to BamHI/
SalI-digested pGEX-4T-1. The cloning junctions were confirmed
by DNA sequence analysis, and the resulting constructs, pGEX-
StFliC and pGEX-BaFliC, were transformed into E. coli BL-21.
Expression of GST::StFliC and GST::BruFliC was induced by
IPTG, and the recombinant flagellins were purified using
Glutathione-Sepharose 4B (GE Healthcare). Protein concentra-
tion was measured with DC protein assay (Bio-Rad).
Preparation of concentrated S. Typhimurium culture
supernatant containing recombinant flagellins
S. Typhimurium strains were grown for 4 to 5 h at 37°C with
vigorous shaking by diluting an overnight culture 1 to 100 in 20 ml
LB broth plus 1 mM IPTG. Once the OD600 reached 0.8 to 1.2,
bacteria were removed by centrifugation at 4000 r.p.m. for 15 min
and 12 ml of the resulting supernatant was passed through a
0.45 mm filter and subject to concentration by using an Amicon
Ultra-15 with cut-off of 5K (Millipore) followed by a wash with
10 ml of phosphate-buffered saline (PBS). Protein concentration
was determined by DC protein assay (Bio-Rad) and SDS-PAGE
Table 1. Bacterial strains and plasmids used in this study.
Designation Genotype and/or phenotype Source or reference
Strains
Brucella melitensis strains
16M Wild type isolate
DfliC DfliC::Kan Ferooz et al. (2011)
DflbT DflbT::Kan Ferooz et al. (2011)
DfliF DfliF::Kan Ferooz et al. (2011)
BruFliCON pBBR1-fliC This work
Brucella abortus strain
2308 Wild type isolate
Salmonella enterica serovar
Typhimurium strains
14028 ATCC 14028 wild type ATCC
IR715 14028 spontaneous NalR Stojiljkovic et al. (1995)
LT2 LT2 wild type Lilleengen (1948)
EHW26 IR715 fliC::Tn10 fljB::MudJ (fliCfljB) Raffatellu et al. (2005)
Escherichia coli strains
CC118 lpir araD139 D(ara, leu)7697 DlacX74 phoAD20 galE galK thi rpsE rpoB
argEam recA1 lpir
Simon et al. (1983)
DH10B F- mcrA D(mrr-hsdRMS-mcrBC) j80lacZDM15 DlacX74 recA1 araD139
D(ara, leu)7697 galU galK rpsL(StrR) endA1 nupG
Invitrogen
DH5a F- mcrA D(mrr-hsdRMS-mcrBC) j80lacDZDM15 D(lacZYA-argF)U169
deoR recA1 endA1 phoA supE44 l- thi-1 gyrA96 relA1
Woodcock et al. (1989)
S17-1 lpir recA thi pro rK– mK+ RP4:2-Tc:MuKm Tn7 lpir Simon et al. (1983)
Plasmids
pCR2.1 TOPO cloning vector Invitrogen
pUC-KIXX pUC4::Tn5 KanR Beck et al. (1982)
pBBR1MCS mob RK2, lacZa, CmR Kovach et al. (1994)
pRH001fliC pMR10 (CmR, B. melitensis 16M PfliC-fliC-tfliC) This work
pBBR1-fliC pBBR1MCS(CmR, B. melitensis 16M fliC) This work
pBBRFlag pBBR1MCS::3xFLAG This work
pYHS1116 pBBRFlag::StFliC This work
pYHS1073 pBBRFlag::BaFliC This work
pWSK29 CarbR, pSC101 ori Wang and Kushner (1991)
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followed by Coomassie blue stain. The final protein concentration
was adjusted to 1 mg ml-1.
Generation of rabbit anti-BaFliC serum and
Western blot
Brucella abortus fliC (BaFliC) was amplified using primers
BaFliC-F and BaFliC-R and cloned into pET103 in frame with a
6xHis tag. The resulting BaFliC::6xHis fusion protein was pro-
duced and purified by using Ni-NTA kit (Qiagen). Rabbit serum
against BaFliC was generated by Antagene (Antagene, CA,
USA). For detection of secreted BaFliC the supernatant from 1 ml
of culture was precipitated using trichloroacetic acid (TCA) and
separated on a 12% SDS-PAGE gel. Proteins were electrotrans-
ferred to a polyvinylidene difluoride (PVDF) membrane. BaFliC
was detected by using rabbit anti-BaFliC as primary antibody and
as goat anti-rabbit IgG conjugated to horseradish peroxidase
(HRP) as secondary antibody. S. Typhimurium Phase I flagellin
(FliC) was detected using Salmonella Hi antiserum (Difco).
C-terminal FLAG-tagged S. Typhimurium and B. abortus flagel-
lins were detected using anti-FLAG monoclonal antibody
(1:5000, Sigma) and a goat anti-mouse IgG antibody conjugated
to HRP. HRP activity was detected with a chemiluminescent
substrate (PerkinElmer Life Sciences). Flagellin produced by
B. melitensis 16M was detected as described previously (Fretin
et al., 2005).
Measurement of TLR5 agonist activity of flagellins
The human colonic epithelial cell line T84 was cultured in Dul-
becco’s modified Eagle’s medium (DMEM)-F12 medium (Gibco),
containing 1.2 g l-1 sodium bicarbonate, 2.5 mM L-glutamine,
15 mM Hepes and 0.5 mM sodium pyruvate (Gibco), supple-
mented with 10% fetal calf serum (FCS). The day before assay,
cells from 1/3 of an 80–90% confluent T75 flask were seeded per
each 24-well plate containing DMEM-F12 and 2% FCS. HEK293
cells were cultured as previously described (Keestra et al., 2010).
T84 cells in 24-well plates were either infected with 10 ml of
bacteria grown as above or treated by adding 30 ml of concen-
trated bacterial culture supernatant and incubated for 4 h at 37°C
under 5% CO2. For the HEK293 stably transfected with human
TLR5, cells were grown in 48-well tissue culture plates and
infected for 4–48 h with 10 ml of bacteria grown as described
above or treated by adding 10 ml of concentrated bacteria culture
supernatant and incubated for 8 h at 37°C under 5% CO2. Super-
natants were aspirated and centrifuged for 10 min at 6000 r.p.m.
to remove residual bacteria and cell debris before measurement
of IL-8 concentration by ELISA.
MAPK phosphorylation assay
T84 cells were seeded in six-well plates at a density of 4 ¥ 108
cells per well and incubated for 24 h in DMEM/F12 + 10% fetal
bovine serum. The following day, cells were rinsed with PBS and
the medium replaced with serum-free medium. For analysis of
MAP kinase phosphorylation, cells were treated with concentra-
tions of GST-BruFliC or GST-StFliC ranging from 250 ng ml-1 to
1 mg ml-1. As a negative control, cells were treated with the
highest concentration of flagellin (1 mg ml-1) that had previously
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at 37°C, then for 10 min at 75°C to inactivate the protease). After
30 and 90 min, cells were lysed 0.1 ml in phosphosafe extraction
reagent (Novagen) containing 2.5% protease inhibitor (Sigma)
according to the instructions of the manufacturer. The protein
concentration was determined using the Micro BCA kit (Pierce).
Total protein (0.01 mg) was resolved by SDS-PAGE and trans-
ferred to a polyvinylidene fluoride membrane. Primary antibodies
were purchased from Cell Signalling Technology, including the
following phosphorylation-specific antibodies: p-ERK and p-p38
(Thr180/Tyr182). Secondary antibodies (goat anti-rabbit conju-
gated to HRP) were purchased from Jackson Immunoresearch
and used according to the recommendations of the manufacturer.
Peroxidase activity was visualized using Immobilon Western
Chemiluminescent HRP Substrate (Millipore). For each primary
antibody, a separate membrane was used.
Detection of flagellin in the cytosol of
infected macrophages
The b-lactamase translocation assay was performed as previ-
ously described (Sun et al., 2007). Briefly, J774A.1 mouse mac-
rophages were seeded in 96-well coverglass bottom plates and
infected with B. abortus 2308 expressing either a BruFliC::Flag-
TEM-1 fusion protein, or an irrelevant control (Glutathione-S-
transferase::Flag-TEM-1) at a multiplicity of infection of 500.
Plates were centrifuged at 250 g for 5 min at room temperature to
synchronize infection. After incubation for 1 h at 37°C in 5% CO2,
free bacteria were removed from the cells by three washes with
PBS. A volume of 0.2 ml of DMEM supplemented with 10%
heat-inactivated fetal bovine serum, 1% non-essential amino
acids, 1 mM glutamine containing 1 mM IPTG and 100 mg ml-1
gentamicin was added to each well, and plates were incubated at
37°C in 5% CO2. After 16 h, cells were washed once with Hank’s
balanced salt solution (Invitrogen) and loaded with the fluores-
cent substrate CCF2/AM (1 mM, Invitrogen) for 1.5 h at room
temperature using the standard loading protocol recommended
by the manufacturer. Fluorescence microscopy analysis was
performed using an Axiovert M200 (Carl Zeiss), equipped with
a CCF2 filter set (Chroma Technology). Fluorescence micro-
graphs were captured using a Zeiss Axiocam MRC5 and Zeiss
AxioVision 4.5 software. Images were imported into Adobe Pho-
toShop for colour adjustment. The number of blue cells contain-
ing cleaved CCF2/AM was counted visually and expressed as
the percentage of total cells in the well. The experiment was
performed four times and the result expressed as geometric
mean and range of the four experiments.
Bone marrow-derived macrophages
Bone marrow-derived macrophages were isolated from C57BL/6,
or congenic mutant mice following standard protocols as
described previously (Sun et al., 2007).
Macrophage infection
For assaying inflammasome activation, 24-well microtitre plates
were seeded with BMDM at a concentration of 2 ¥ 105 cells/well
in 0.5 ml of RPMIsup and incubated overnight at 37°C in 5% CO2.
For priming of macrophages, cells were treated for 4 h before
infection with LPS (100 ng ml-1), as previously described
(Franchi et al., 2006).
Inocula of B. melitensis 16M were prepared by growing with
shaking in TSB for 24 h. Bacteria were treated with a non-
agglutinating (1:4000) dilution of anti-Brucella rabbit serum
(Difco) for 1 h at 37°C, as described (Rolan and Tsolis, 2007),
then diluted in RPMIsup to a concentration of 4 ¥ 107 CFU ml-1.
Approximately 2 ¥ 107 bacteria in 0.5 ml of RPMIsup, containing
B. melitensis 16M wt or its isogenic fliC mutant, were added to
each well of macrophages. Three independent assays were per-
formed with triplicate samples, and each experiment included
control (C57BL/6) macrophages together with macrophages from
mutant mice. Microtitre plates were centrifuged at 250 g for 5 min
at room temperature in order to synchronize infection. Cells were
incubated for 20 min at 37°C in 5% CO2, and free bacteria were
removed by three washes with PBS. RPMIsup plus 50 mg ml-1
gentamicin was added to the wells, and the cells were incubated
at 37°C in 5% CO2. After 1 h, the RPMIsup plus 50 mg ml-1
gentamicin was replaced with medium containing 25 mg ml-1 gen-
tamicin. Wells were sampled after infection by aspirating the
medium, lysing the macrophages with 0.5 ml of 0.5% Tween-20
and rinsing each well with 0.5 ml of PBS. Viable bacteria were
quantified by dilution in sterile PBS and plating on TSA containing
appropriate antibiotics.
Liposome-mediated delivery of flagellins to the
macrophage cytosol
Recombinant flagellin proteins were delivered to the macrophage
cytosol using the cationic lipid DOTAP (Roche), as described
previously (Franchi et al., 2006). Briefly, 50 ml of DOTAP was
incubated for 30 min in serum-free media with 2 mg of recom-
binant flagellins purified as described above. After incubation,
3.5 ml of serum-free media was added and 500 ml was used to
stimulate 1 ¥ 106 macrophages seeded in 24-well microtitre
plates for 3 h.
Measurement of cytokines
Mouse IL-1b was measured in culture supernatants by enzyme-
linked immunoabsorbent assay (ELISA) (R&D Systems). Human
IL-8 was detected using an ELISA kit from BioLegend.
Mice
Wild type (wt) BALB/c, wt C57BL/6, C57BL/6 Nlrc4-/- (obtained
from Dr V.M. Dixit and described in Mariathasan et al., 2004) and
C57BL/6 Casp1-/- (obtained from Dr R. Flavell and described in
Kuida et al., 1995) mice were used in this study. They were bred
in the animal facility of the University of Namur (Belgium). The
animal handling and procedures of this study were in accordance
with the current European legislation (directive 86/609/EEC) and
in agreement with the corresponding Belgian law ‘Arrêté royal
relatif à la protection des animaux d’expérience du 6 avril 2010
publié le 14 mai 2010’. The complete protocol was reviewed and
approved by the Animal Welfare Committee of the University of
Namur, Belgium (Permit Number: 05-558).
Infection of mice
Mice were injected intraperitoneally (i.p.) with 4 ¥ 104 CFUs of
B. melitensis 16M in 500 ml of PBS. Control animals were
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injected with the same volume of PBS. Infectious doses were
validated by plating serial dilutions of the inocula. At selected time
intervals, mice were sacrificed by cervical dislocation. Immedi-
ately after being killed, spleen and liver were collected for bac-
terial counts and histopathological analyses. For bacterial
counts, spleens and livers were homogenized in PBS/0.1%
X-100 triton (Sigma). Serial dilutions were plated on 2YT media
plates for enumeration of tissue-associated CFU.
Histology
Spleens were fixed for 24 h in Bouin’s fixative, dehydrated for
24 h in methanol, then incubated in toluol and finally in warm
paraffin prior to paraffin embedding. Sections (5 mm) were rehy-
drated and stained with hemalun, erythrosin and safran. Blinded
histopathology scoring for splenic granuloma formation was per-
formed by a pathologist (M.N.X.), according to the following cri-
teria. 0, < 5% of splenic parenchyma containing granulomas; 1,
5–20%; 2, 20–40%; 3, 40–60%; 4, > 60%.
Immunofluorescence microscopy
Spleens were fixed for 6 h at 4°C in 2% paraformaldehyde
(pH 7.4), washed in PBS, incubated overnight at 4°C in a 20%
PBS-sucrose solution under agitation, and washed again in PBS.
Tissues were embedded in the Tissue-Tek OCT compound
(Sakura), frozen in liquid nitrogen, and cryostat sections (10 mm)
were prepared. Tissues sections were rehydrated in PBS, then
incubated successively in a PBS solution containing 1% blocking
reagent (Boeringer) (PBS-BR 1%) and in PBS-BR 1% containing
any of the following mAbs or reagents: DAPI nucleic acid stain,
Alexa Fluor 350 phalloidin, M1/70 (anti-CD11b, BD Biosciences),
home-made anti-B. melitensis 16M serum (Copin et al., 2012).
Slides were mounted in Fluoro-Gel medium (Electron Microscopy
Sciences, Hatfield, PA, USA). Labelled tissue sections were visu-
alized under a Zeiss fluorescent inverted microscope (Axiovert
200) equipped with high-resolution monochrome camera
(AxioCam HR, Zeiss).
Statistical analysis
ANOVA I was used for infection data analysis after testing the
homogeneity of variance (Bartlett test). Average comparisons
were performed by pairwise Scheffe’s test. A Mann–Whitney test
was used for analysis of histopathology scoring. Error bars rep-
resent standard deviation.
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